Renegotiated licensing agreement and information about the first day of trade

The licensing agreement with CombiGene has recently been renegotiated. The revised agreement is now finalized and statements concerning CombiGene's entitlement to withdrawal have been reformulated. Levels of remuneration to Panion in the event of a withdrawal have also been adjusted.

Since the licensing agreement is of material significance for Panion's business operation, it has not been possible to complete the application for listing on AktieTorget. With the finalization of the agreement, Panion hopes to be able to announce a date for the start of trading on AktieTorget within the very near future.

3 JULI 2017

For further information, please contact:
Anja E. H. Holm, VD | + 45-22 94 66 00

In June 2015 CombiGene formed a wholly owned subsidiary, then called CombiGene Vet AB, and in April 2016 the decision was taken to distribute the subsidiary to CombiGene's shareholders with the aim of listing the company. The company, which has been renamed Panion Animal Health AB, will use CombiGene's discoveries to develop a treatment for canine epilepsy. Panion aims at inlicensing or acquiring other veterinary medicine projects or products.


Period April-June

  • Net sales: kSEK 0 (0)
  • Operating profit: kSEK -1 269 (0)
  • Earnings per share: SEK -0,10 (-).
  • Liquidity at the end of the period: kSEK 796 (582).

Period January-June

  • Net sales: kSEK 0 (0). 
  • Operating profit: kSEK -2 536 (-). 
  • Earnings per share: SEK -0,21 (-). 
  • Liquidity at the end of the period: kSEK 796 (582).

Panion has made an agreement with Copenhagen University about transfer and use of technical data from a study in dogs. 


After raising new capital, veterinary medicine company Panion Animal Health AB is now ready to ramp
up development of its treatment method for canine epilepsy. At the same time, discussions are under
way for a licensing deal that could give Panion access to a new major market.


Panion Animal Health AB (publ) ("Panion") has received approval for admission to trading of its shares on AktieTorget. The listing of Panion on AktieTorget facilitates distribution of CombiGene's shares in Panion to CombiGene's shareholders. The first day of trading in Panion's share on AktieTorget is Thursday, 6 July 2017.



Press releases and reports via E-mail.